Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemiaStephen Breit, Andreas E. Kulozik|Blood|2006Cited by 293
Plasticity of nuclear and cytoplasmic stress responses of RNA-binding proteinsMichael Backlund, Andreas E. Kulozik|Nucleic Acids Research|2020Cited by 66
Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient‐derived osteosarcoma cells and synergizes with cisplatin and talazoparibChristopher L. Heidler, Andreas E. Kulozik|International Journal of Cancer|2019Cited by 26
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibitionClemens Stockklausner, Andreas E. Kulozik|Aging|2015Cited by 17
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcomaYang Zhou, Andreas E. Kulozik|Nature Communications|2024Cited by 10